{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-133745","form_type":"8-K","ticker":"TSHA","cik":"0001806310","company_name":"Taysha Gene Therapies, Inc.","filed_at":"2025-06-03T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.801971+00:00","generated_at":"2026-05-20T01:50:14.154383+00:00","sec_items":["5.03","5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Taysha Gene Therapies shareholders approve authorized share increase to 700M","bullets":["Authorized common stock increased from 400M to 700M shares; approved 171.3M for, 8.2M against.","Directors Phillip B. Donenberg and Sukumar Nagendran elected with 114.3M and 123.3M votes for, respectively.","Deloitte & Touche ratified as independent auditor for FY2025; 179.4M votes for.","Annual meeting turnout: 179.6M shares (~87%) of 205.1M outstanding represented."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-133745","json":"https://secwatch.observer/filing/0001193125-25-133745.json","markdown":"https://secwatch.observer/filing/0001193125-25-133745.md","text":"https://secwatch.observer/filing/0001193125-25-133745.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1806310/000119312525133745/0001193125-25-133745-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1806310/000119312525133745/d843671d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-20T01:50:14.154383+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"c95637abd338de86f0119b9cab91db7195a88e7d","claim":"Taysha Gene Therapies, Inc.: Increase in authorized common stock from 400,000,000 to 700,000,000 (effective 2025-06-02).","evidence_excerpt":"At the Annual Meeting, the Company’s stockholders approved an amendment to the Company’s Amended and Restated Certificate of Incorporation (the “ Amendment ”) to increase the authorized number of shares of common stock from 400,000,000 to 700,000,000.","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1806310/000119312525133745/0001193125-25-133745-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"charter amendment"},{"label":"Effective","value":"2025-06-02"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}